Mirabegron/Tamsulosin Hydrochloride

米拉贝隆/盐酸坦洛新

Report date: 2025/07/31 10:53:52

Base Information

Drug NameMirabegron/Tamsulosin Hydrochloride
Drug Alias NameBR-9006
ClassificationSmall molecules
Mechanisms of ActionBeta-3 adrenergic receptor agonistsAlpha-1a adrenergic receptor antagonists
TargetsBeta-3 adrenergic receptorAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A